---

---

tags : Therapeutics    symbols : Nvo   

save search

---

Ventus Therapeutics Announces Results from Phase 1 Clinical Trial of VENT-02, a Novel, Orally Administered, Brain-Penetrant NLRP3 Inhibitor
Published: 2024-04-17 (Crawled : 14:00) - biospace.com/
NVO | $124.37 1.32% 740K |

Health Technology

| 0.87% | O: 1.22% H: 0.21% C: -0.34%
vent-02 trial therapeutics results

---

Ventus Therapeutics to Present at 2024 Bloom Burton & Co. Healthcare Investor Conference
Published: 2024-04-08 (Crawled : 12:30) - biospace.com/
NVO | $124.37 1.32% 740K |

Health Technology

| -0.35% | O: 1.62% H: 0.5% C: 0.36%
conference therapeutics

---

Beta-thalassemia Market to Witness Upsurge in Growth During the Study Period (2019-2032), Evaluates DelveInsight | Leading Companies - Vertex Pharmaceuticals, CRISPR Therapeutics, Agios Pharmaceuticals, Celgene, Forma Therapeutics
Published: 2024-01-17 (Crawled : 22:00) - prnewswire.com
NVO | $124.37 1.32% 740K |

Health Technology

| 16.73% | O: -0.36% H: 1.32% C: 1.18%
JNJ | News | $146.315 0.4% 1.3M |

Health Technology

| -9.56% | O: -0.21% H: 0.0% C: 0.0%
VRTX | News | $396.83 0.85% 190K |

Health Technology

| -8.95% | O: -0.5% H: 0.76% C: 0.32%
EDIT | $5.635 1.53% 200K |

Health Technology

| -34.01% | O: 0.83% H: 0.35% C: -3.66%
AGIO | News | $30.24 2.75% 180K |

Health Technology

| 34.27% | O: 0.41% H: 0.0% C: -2.2%
crispr companies therapeutics growth study market

---

Focal Segmental Glomerulosclerosis Market to Observe Impressive Growth by 2032, Predicts DelveInsight | Leading Companies - ACELYRIN, Genentech, ChemoCentryx, Travere Therapeutics, Boehringer Ingelheim, Chinook Therapeutics
Published: 2024-01-10 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $92.7 600K |

Health Technology

| -10.95% | O: 1.1% H: 0.0% C: 0.0%
NVO | $124.37 1.32% 740K |

Health Technology

| 14.59% | O: -0.33% H: 0.35% C: -1.5%
LLY | $745.04 -0.12% 410K |

Health Technology

| 19.13% | O: 0.67% H: 0.85% C: 0.21%
SNY | News | $46.135 1.64% 270K |

Health Technology

| -12.45% | O: 0.69% H: 0.0% C: 0.0%
ALDX | News | $3.945 -0.88% 49K |

Health Technology

| 19.16% | O: -1.8% H: 0.46% C: -2.44%
companies therapeutics growth market

---

Novo Nordisk enters into research collaborations with Omega Therapeutics and Cellarity on novel treatment approaches for cardiometabolic diseases
Published: 2024-01-04 (Crawled : 11:00) - globenewswire.com
OMGA | $2.4 -0.83% 16K |

| -6.23% | O: 92.31% H: 20.0% C: 1.24%
NVO | $124.37 1.32% 740K |

Health Technology

| 20.18% | O: 1.44% H: 3.68% C: 2.4%
treatment research therapeutics

---

Hoba Therapeutics raises EUR 23 million in a Series A to advance new drug candidate against chronic neuropathic pain
Published: 2023-12-11 (Crawled : 07:00) - prnewswire.com
NVO | $124.37 1.32% 740K |

Health Technology

| 28.86% | O: -0.22% H: 0.68% C: 0.23%
drug candidate series therapeutics

---

Addressing the Global HIV Challenge: Market for Diagnostics and Therapeutics Plays a Crucial Role in Combating HIV/AIDS
Published: 2023-11-03 (Crawled : 17:00) - prnewswire.com
TRUMF | $16.928 1.9K |

Health Technology

| -38.28% | O: -0.28% H: 4.55% C: 0.01%
SNYNF | News | $92.7 600K |

Health Technology

| 0.22% | O: -1.79% H: 0.0% C: 0.0%
NVSEF | $93.6375 6.88% 82K |

Health Technology

| 0.42% | O: -1.88% H: 3.51% C: 2.73%
TRUMY | $16.507 34K |

Manufacturing

| -40.92% | O: 3.89% H: 0.0% C: -1.74%
TMO | News | $542.82 0.24% 190K |

Health Technology

| 19.94% | O: 2.32% H: 0.0% C: 0.0%
QGEN | $39.8 0.84% 47K |

Health Technology

| 2.62% | O: 2.12% H: 1.06% C: 0.51%
NVO | $124.37 1.32% 740K |

Health Technology

| 23.38% | O: -2.23% H: 0.16% C: -0.52%
NVS | $93.43 0.93% 220K |

Health Technology

| -1.06% | O: -1.4% H: 0.42% C: 0.0%
JNJ | News | $146.315 0.4% 1.3M |

Health Technology

| -1.83% | O: 2.15% H: 0.0% C: 0.0%
BDX | $234.61 0.63% 120K |

Health Technology

| -9.73% | O: 1.1% H: 0.33% C: 0.07%
SNY | News | $46.135 1.64% 270K |

Health Technology

| -3.19% | O: -3.04% H: 0.0% C: 0.0%
QGEN | $39.75 0.71% 41K |

Health Technology

| 2.62% | O: 2.12% H: 1.06% C: 0.51%
global hiv diagnostics therapeutics market

---

MapLight Therapeutics Closes $225 Million Series C Funding Round to Advance Pipeline of Central Nervous System Therapeutics
Published: 2023-10-30 (Crawled : 18:00) - biospace.com/
NVO | $124.37 1.32% 740K |

Health Technology

| 33.19% | O: 3.44% H: 0.71% C: -0.33%
pipeline series system therapeutics funding

---

Vect-Horus Enters Exclusive License Agreement with Novo Nordisk to Develop Targeted Therapeutics
Published: 2023-10-30 (Crawled : 14:00) - biospace.com/
NVO | $124.37 1.32% 740K |

Health Technology

| 33.19% | O: 3.44% H: 0.71% C: -0.33%
license therapeutics agreement

---

OnKure Therapeutics Appoints Ann Howell, Pharm.D., as Vice President of Regulatory Affairs
Published: 2023-09-20 (Crawled : 17:00) - biospace.com/
NVO | $124.37 1.32% 740K |

Health Technology

| 33.15% | O: 1.26% H: 1.82% C: 0.03%
therapeutics

---

Peptide Therapeutics Global Market Report 2023: Increase in the Prevalence of Chronic Diseases Drives Growth
Published: 2023-06-01 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $92.7 600K |

Health Technology

| -8.59% | O: -0.56% H: 0.0% C: 0.0%
AZNCF | $138.24 -1.36% 0 |

Health Technology

| -8.39% | O: -0.74% H: 1.4% C: 0.35%
NVSEF | $93.6375 6.88% 82K |

Health Technology

| 15.61% | O: 0.99% H: 0.0% C: 0.0%
TAK | News | $13.235 0.57% 100K |

Health Technology

| -17.24% | O: 1.32% H: 0.31% C: 0.12%
PFE A | $25.44 0.2% 4.4M |

Health Technology

| -33.14% | O: 0.6% H: 1.07% C: 0.29%
NVO | $124.37 1.32% 740K |

Health Technology

| -21.17% | O: -1.84% H: 1.62% C: 1.33%
NVS | $93.43 0.93% 220K |

Health Technology

| -4.15% | O: 1.03% H: 0.84% C: 0.82%
BMY | $48.295 -0.01% 920K |

Health Technology

| -25.32% | O: 0.37% H: 1.34% C: 1.14%
SNY | News | $46.135 1.64% 270K |

Health Technology

| -9.41% | O: 1.05% H: 0.0% C: 0.0%
AZN | $68.505 0.21% 580K |

Health Technology

| -6.28% | O: 0.11% H: 0.69% C: -0.45%
report global therapeutics growth market

---

Novo Nordisk and Life Edit Therapeutics establish multi-target collaboration to discover and develop gene editing therapies for rare and cardiometabolic diseases
Published: 2023-05-24 (Crawled : 10:00) - globenewswire.com
NVO | $124.37 1.32% 740K |

Health Technology

| -23.83% | O: -0.59% H: 0.25% C: -0.45%
rare life collaboration therapeutics

---

Global Protein Therapeutics Market Report 2023: Development of Plasma Derived Therapies Drives Growth
Published: 2023-05-23 (Crawled : 02:00) - prnewswire.com
AZNCF | $138.24 -1.36% 0 |

Health Technology

| -8.52% | O: 0.7% H: 1.22% C: -0.67%
NVO | $124.37 1.32% 740K |

Health Technology

| -26.97% | O: -1.39% H: 0.06% C: -2.77%
JNJ | News | $146.315 0.4% 1.3M |

Health Technology

| -7.6% | O: 0.15% H: 0.74% C: -0.18%
LLY | $745.04 -0.12% 410K |

Health Technology

| 72.99% | O: -0.25% H: 0.69% C: -2.24%
ABT | News | $107.145 1.78% 1.3M |

Health Technology

| -1.71% | O: -0.88% H: 0.17% C: -1.45%
ORMP | $2.215 0.68% 11K |

Health Technology

| -47.4% | O: 0.9% H: 10.29% C: 0.0%
AZN | $68.505 0.21% 580K |

Health Technology

| -8.31% | O: 0.97% H: 0.0% C: -1.46%
report global protein therapeutics growth market

---

Ray Therapeutics Closes Oversubscribed $100M Series A Financing to Advance Optogenetic Gene Therapies for Blinding Diseases
Published: 2023-05-16 (Crawled : 14:00) - biospace.com/
NVO | $124.37 1.32% 740K |

Health Technology

| -26.5% | O: -1.48% H: 1.06% C: 0.44%
ray therapeutics

---

Aspect Biosystems and Novo Nordisk enter partnership to develop bioprinted tissue therapeutics for diabetes and obesity
Published: 2023-04-12 (Crawled : 09:00) - globenewswire.com
NVO | $124.37 1.32% 740K |

Health Technology

| -21.37% | O: 1.82% H: 2.28% C: 1.4%
partnership obesity biosystems therapeutics diabetes

---

Biora Therapeutics Announces Bioavailability Results for Oral Delivery of GLP-1 Receptor Agonist
Published: 2023-02-23 (Crawled : 15:00) - globenewswire.com
BIOR | $0.609 1.59% 8.8K |

Health Care and Social Assistan...

| -78.59% | O: -1.03% H: 5.57% C: 5.57%
NVO | $124.37 1.32% 740K |

Health Technology

| -12.46% | O: 0.63% H: 0.48% C: -0.17%
agonist therapeutics

---

Press Release: Sanofi and Innate Pharma expand collaboration for natural killer cell therapeutics in oncology
Published: 2022-12-19 (Crawled : 07:00) - globenewswire.com
IPHYF | $2.65 104.6% 300 |

Health Technology

| 21.31% | O: 21.77% H: 0.0% C: 0.0%
SNYNF | News | $92.7 600K |

Health Technology

| 0.49% | O: 1.54% H: 0.51% C: -0.25%
NVO | $124.37 1.32% 740K |

Health Technology

| -6.49% | O: -1.82% H: 0.23% C: -0.11%
SNY | News | $46.135 1.64% 270K |

Health Technology

| -2.13% | O: 1.14% H: 0.0% C: 0.0%
IPHA | $2.35 1.5K |

Health Technology

| 23.68% | O: 35.79% H: 10.85% C: 2.71%
pharma collaboration natural therapeutics sanofi

---

Novo Holdings and Sound Bioventures launch Breye Therapeutics to develop novel oral therapies for ophthalmologic diseases
Published: 2022-11-10 (Crawled : 09:00) - prnewswire.com
NVO | $124.37 1.32% 740K |

Health Technology

| 9.07% | O: 2.04% H: 0.17% C: -0.82%
therapeutics

---

Diabetes Therapeutics Market Worth $91+ Billion, Globally, by 2028 at 6+% CAGR | The Insight Partners
Published: 2022-10-19 (Crawled : 11:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K |

Health Technology

| 48.61% | O: -1.98% H: 0.0% C: 0.0%
TAK | News | $13.235 0.57% 100K |

Health Technology

| 3.46% | O: -1.18% H: 0.56% C: -1.11%
NVO | $124.37 1.32% 740K |

Health Technology

| 16.71% | O: -0.38% H: 0.04% C: -1.58%
NVS | $93.43 0.93% 220K |

Health Technology

| 20.12% | O: -0.52% H: 0.06% C: -0.75%
JNJ | News | $146.315 0.4% 1.3M |

Health Technology

| -12.16% | O: 0.46% H: 0.0% C: 0.0%
GSK | $39.565 0.75% 170K |

Health Technology

| 26.72% | O: 0.96% H: 0.22% C: -0.76%
SNY | News | $46.135 1.64% 270K |

Health Technology

| 12.2% | O: -1.37% H: 0.0% C: 0.0%
therapeutics diabetes market

---

Novo Nordisk announces the completion of the Forma Therapeutics acquisition
Published: 2022-10-14 (Crawled : 13:00) - globenewswire.com
NVO | $124.37 1.32% 740K |

Health Technology

| 18.79% | O: 0.03% H: 0.35% C: -1.01%
acquisition therapeutics

---

Gainers vs Losers

81%

19%

Top 10 Gainers

AGBA | News | $1.37 242.5% 76M |

Finance

EGOX | $0.0835 131.94% 160M |

ZCMD | $2.18 50.35% 24M |

Commercial Services

CHRO | $1.73 41.22% 46K |

n/a

RWOD | $10.61 32.68% 5.1M |

n/a

NVFY | $2.77 31.28% 2.2M |

Consumer Durables

AULT | $0.3174 31.1% 28M |

Manufacturing

WISA 4 | $7.11 20.71% 4.7M |

Electronic Technology

LIFW | News | $0.99 19.26% 800K |

Administrative and Support and ...

PRTG | $0.285 18.75% 140K |

Mining, Quarrying, and Oil and ...

---

Your saved searches

---